{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015526","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.394363+00:00","generated_at":"2026-05-30T01:27:36.129852+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Armata Pharma Q3 net loss $5.5M; Phase 2 Tail wind enrolled, topline data expected by year-end","bullets":["Net loss $5.5M ($0.15/share) vs $31.2M loss in Q3 2023; includes $6.9M non-cash gain on convertible debt.","Grant revenue $3.0M (DoD/MTEC) vs $1.2M; R&D expense $9.5M; cash $17.1M as of Sep 30, 2024.","Phase 2 Tail wind (inhaled AP-PA02 for NCFB) enrollment complete; topline data expected by year-end 2024.","Phase 1b/2a diSArm (IV AP-SA02 for S. aureus bacteremia) enrollment complete; topline data Q1 2025.","Extended convertible debt and credit agreement maturity to Jan 10, 2026; appointed David House SVP Finance."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015526","json":"https://secwatch.observer/filing/0001558370-24-015526.json","markdown":"https://secwatch.observer/filing/0001558370-24-015526.md","text":"https://secwatch.observer/filing/0001558370-24-015526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000155837024015526/0001558370-24-015526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000155837024015526/armp-20241113x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:27:36.129852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}